Weitz & Luxenberg is accepting cases of people implanted with the first-generation Smith & Nephew Journey Bi-cruciate Stabilized (BCS) Knee replacement system (Journey I BCS Knee System) who have either had revision surgery or been told by their doctor that they will require revision surgery due to loosening of the knee implant’s femoral component.
Study and registry data have shown that the Journey I BCS Knee System has higher rates of revision surgery when compared to other similar total knee arthroplasty (TKA) devices.
Knee Replacement System Recalled
Smith & Nephew phased out the first-generation Journey I BCS Knee System in 2013-2014.
However, Smith & Nephew’s Memphis, TN-based orthopedics division did not issue an Urgent Field Safety Notice warning customers about the higher rate of revision with the first-generation Journey BCS until June of 2018. The notice cited data from the National Joint Registry of England, Wales, and Northern Ireland and the Australian Orthopaedic Association National Joint Replacement Registry that indicated the first-generation Journey I BCS Knee System had a revision rate more than 1.5 times higher than revision rates of comparable primary TKA devices. Another study, partially funded by Smith & Nephew and published in 2018, found the risk of revision for the original Journey I BCS Knee was nearly 4.2 times higher than that of the Journey II second-generation device.
Following Smith & Nephew’s issuing of the Field Safety Notice, the U.S. Food and Drug Administration (FDA) issued a Class II recall for first-generation Journey BCS Knee Systems in October of 2018.
W&L Can Help Patients Harmed by Smith & Nephew’s Recalled Journey BCS Knee System
Attorneys with Weitz & Luxenberg’s Drug and Medical Device Litigation unit are interested in hearing from anyone who has had surgery with a Smith & Nephew first-generation Journey BCS Knee System and subsequently experienced device failure or component loosening necessitating revision surgery.
Contact us if:
- You or your loved one have a Journey I BCS Knee System implanted after 2010, and
- You or your loved one have had a revision surgery due to femoral component loosening, or
- You or your loved one have been advised that you will require revision surgery due to femoral component loosening.
Patients may be entitled to compensation for medical expenses, pain and suffering, lost wages, and other costs. An experienced Weitz & Luxenberg attorney can help you explore all legal options.
W&L’s Drug and Medical Device Litigation unit co-chair Ellen Relkin has played a lead role in major medical device litigations, including helping to secure a $2.5 billion settlement for patients harmed by defective DePuy ASR hip implants and a $1 billion resolution over recalled Stryker Rejuvenate and ABG II hip implants.*
Weitz & Luxenberg is ready to assist you and offers a free consultation. Contact us at (833) 544-0604 or by using the online form on this page to discuss your legal options.
*Past performance is no guarantee of future results. The settlements in which Weitz & Luxenberg played leadership roles included patients not represented by W&L.